Bristol-Myers Squibb Company
BMYLast close · Oct 16, 202659.75−0.82 (−1.35%)
Market cap$122.1B
Of the 85 managers this site tracks, 8 held Bristol-Myers Squibb (BMY) at the end of Q2 2026, their latest 13Fs. The largest position by value was Richard Pzena's, $979.9M; John Rogers's ($40.1M) and Kahn Brothers's ($10.0M) follow. No Schedule 13D or 13G is on file for BMY from the activists and large holders the site follows.
Superinvestors holding BMY
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management LLC | Q2 2026 | 17M | $979.9M |
| John Rogers | Ariel Investments, LLC | Q2 2026 | 696,430 | $40.1M |
| Kahn Brothers | Kahn Brothers Group Inc | Q2 2026 | 174,152 | $10.0M |
| Bill Miller | Miller Value Partners, LLC | Q2 2026 | 69,500 | $4.0M |
| Hillman Capital | Hillman Capital Management, Inc. | Q2 2026 | 45,235 | $2.6M |
| Dodge & Cox | Dodge & Cox | Q2 2026 | 42,361 | $2.4M |
| Tweedy Browne | Tweedy, Browne Co LLC | Q2 2026 | 37,570 | $2.2M |
| Mairs & Power | Mairs & Power Inc | Q2 2026 | 24,684 | $1.4M |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.